Dr. Martin M. Matzuk's lab at Baylor College of Medicine focuses on innovative areas of reproductive biology, particularly in developing new male contraceptives and therapeutic options for conditions like endometriosis. The lab uses advanced drug discovery techniques to target specific proteins called kinases, which play crucial roles in fertility and reproductive health. By exploring these biological processes, the lab aims to create effective non-hormonal contraceptives and medications that improve women's health outcomes, especially for those suffering from endometriosis.

Dr. Nicholas Tran's lab at Baylor College of Medicine focuses on understanding how different types of retinal ganglion cells respond to injury and treatments aimed at promoting healing and recovery. They conduct research exploring the links between cellular activity, cell type resilience, and the potential for axon regeneration following damage. The ultimate goal is to enhance therapies for conditions like glaucoma that lead to vision loss.

Dr. Thomas Westbrook's lab at Baylor College of Medicine focuses on developing innovative strategies to treat triple-negative breast cancer (TNBC), a particularly aggressive form of cancer. The lab studies how manipulating RNA splicing can activate the immune response against tumors, potentially improving the efficacy of cancer therapies. By understanding the relationship between RNA splicing and immune signaling, the lab aims to enhance treatment outcomes for TNBC patients.

Dr. Sue Ellen Crawford's lab at Baylor College of Medicine focuses on understanding how rotavirus (RV) infection influences the metabolism of host cells, particularly related to lipid accumulation and degradation of certain proteins. The lab studies the mechanisms by which RV reprograms cellular pathways to enhance its replication and cause severe gastrointestinal issues, especially in young children. Their research aims to uncover reasons behind the life-threatening nature of RV infections and explore potential therapeutic approaches.

Dr. Melanie Samuel's lab at Baylor College of Medicine focuses on understanding how dopamine affects blood vessel growth in the retina. The research explores the role of retinal ganglion cells as sources of dopamine and how this influences vascular integrity in the eye. The ultimate goal is to uncover mechanisms that may lead to new treatments for eye diseases linked to vascular issues, like diabetic retinopathy.

Dr. Fritz J. Sedlazeck's lab at Baylor College of Medicine focuses on improving the understanding of complex regions in the human genome, particularly those that impact cardiovascular disease risk. The lab develops innovative graph genome methods to analyze medically relevant genes, which will help identify genetic variants associated with diseases. Their work utilizes extensive genomic data and aims to make genetic analysis accessible to a broader community, ultimately contributing to better diagnostics and therapies for various conditions.

Dr. Pawel Stankiewicz's lab at Baylor College of Medicine focuses on understanding the genetic causes of severe lung disorders in newborns, specifically lethal lung developmental disorders like alveolar capillary dysplasia. The team investigates how specific genetic variants affect lung development and contribute to serious conditions like pulmonary arterial hypertension. Their ultimate goal is to improve diagnosis and treatment options for these disorders through a better understanding of genetic mechanisms.

Eric Tanifum's lab at Baylor College of Medicine focuses on understanding and treating Parkinson's disease through innovative approaches. The lab is developing nano-sized scavengers that target misfolded proteins implicated in the disease to both diagnose and treat it. By using techniques like advanced imaging and cellular analysis, they aim to uncover new methods for slowing or halting disease progression.

Dr. Margaret A. Goodell's lab focuses on understanding clonal hematopoiesis (CH), a pre-cancerous condition where certain blood cells expand due to genetic mutations. The lab investigates how different stressors, like inflammation and environmental factors, interact with these mutations to influence the risk of developing blood cancers. By using innovative mouse models and analyzing data from large human studies, their aim is to identify modifiable factors that could prevent the progression of CH into malignancies.

The lab of Dr. Ronald J. Parchem at Baylor College of Medicine focuses on understanding how certain microRNAs influence brain development, particularly in relation to congenital hydrocephalus. By studying the MIR302 family of microRNAs, the lab investigates the timing and regulation of neural stem cell differentiation, which is crucial for proper brain structure formation. This research aims to uncover the molecular mechanisms underlying neurodevelopmental disorders and could lead to new therapeutic approaches for brain malformations.

Dr. Nora Vanegas-Arroyave's lab studies the causes of apathy in patients with Alzheimer's disease and other dementias. They aim to understand how changes in the brain affect motivation and goal-directed behavior. Using neuroimaging and electrical stimulation techniques, the lab investigates ways to improve the quality of life for patients by developing targeted treatments for apathy.

Dr. Richard E. Lloyd's lab at Baylor College of Medicine focuses on the relationship between viral infections and the immune responses that can lead to autoimmune diseases like Type 1 Diabetes in children. The research examines how prolonged infections with enteroviruses might trigger immune changes associated with this disease. Through this work, the lab aims to provide insights that could lead to preventive strategies for Type 1 Diabetes.

Dr. Xander H.T. Wehrens' lab at Baylor College of Medicine focuses on understanding atrial fibrillation, a common heart rhythm disorder. The team investigates the molecular mechanisms that contribute to this condition, including the roles of inflammation and specific signaling pathways that lead to abnormal heart activity. Through innovative models and techniques, their goal is to uncover new strategies for prevention and treatment of atrial fibrillation and related complications.